Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): A pilot study of the EBMT SAA working party

Blood

Volumn 85, Issue 5, 1995, Pages 1348-1353

  Bacigalupo, A ^a   Broccia, G ^a   Corda, G ^a   Arcese, W ^a   Carotenuto, M ^a   Gallamini, A ^a   Locatelli, F ^a   Mori, P G ^a   Saracco, P ^a   Todeschini, G ^a   Coser, P ^a   Lacopino, P ^a   Van Lint, M T ^a   Gluckman, E ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY;

ADULT; AGED; APLASTIC ANEMIA; ARTICLE; CALCULATION; CHILD; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG TOLERANCE; FEMALE; HLA SYSTEM; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0028913625     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v85.5.1348.bloodjournal8551348     Document Type: Article

References (30)

1. Speck B, Gluckman E, Haak HL, Van Rood JJ: Treatment of aplastic anemia by antithymocyte globulin with and without allogeneic bone marrow infusions. Lancet 2:1145, 1977
2. Young NS, Alter BP: Definitive treatment of acquired aplastic anemia, in Young NS, Alter BP (eds): Aplastic Anemia: Acquired and Inherited. Philadelphia, PA, WB Saunders Co, 1993, p 159
3. Bacigalupo A, Chaple M, Hows J, Van Lint MT, McCann S, Milligan D, Chessels J, Goldstone AH, Ottolander J, van't Veer ETh, den Ostendorf GJ, Comotti B, Coser P, Broccia G, Bosi A, Locasciulli A, Catalano L, Battista R, Arcese W, Carotenuto M, Marmont AM, Gordon Smith EC: Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: A randomized trial from the EBMT SAA Working Party. Br J Haematol 83:145, 1993
4. Schrezenmeier H, Schandler M, Ragavashar A: Cyclosporin A in aplastic anemia - Report of a workshop. Ann Hematol 65:33, 1992
5. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio, Leverger G, Leporrier M, Reiffers J, Janvier M, Michallet M, Stryckmans P: Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 79:2540, 1992
6. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrman F, Freund M, Meusers P, Salama A. Heimpel H: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297, 1991
7. Frickhofen N, for the German Aplastic Anemia Study Group: Antilymphocyte globulin and methylprednisolone with or without cyclosporin A for treatment of aplastic anemia, in Ragavashar A, Schrezenmeier H, Frickhofen N (eds): Aplastic Anemia: Current Perspectives on the Pathogenesis and Treatment. Wien, Austria, Blackwell-MZV, p 118
8. Ganser A: Therapeutic use of hemopoietic growth factors in patients with aplastic anemia, in: Aplastic Anemia: Current Perspectives on the Pathogenesis and Treatment. Wien, Austria, Blackwell-MZV, p 118
9. Marsh J, Sociè G, Schrezenmeier H, Tichelli A, Gluckman E, Ljungman P, McCann SR, Raghavachar A, Marin P, Hows JM, Bacigalupo A: Hemopoietic growth factors in aplastic anaemia: A cautionary note. Lancet 1994 (in press)
10. Potter MN, Mott MG, Oakhill A: The successful treatment of a case of very severe aplastic anemia with GM-CSF and antilymphocyte globulin. Br J Haematol 75:618, 1990
11. Gordon Smith EC, Yandle A, Milne A, Speck B, Marmont AM, Willemze R. Kolb HJ: Randomized placebo controlled study of rhGM-CSF following ALG in the treatment of aplastic anemia. Bone Marrow Transplant 2:78, 1991 (suppl 2)
12. Sonoda Y, Ashige H, Fujii H, Tsuda S, Naekawa T, Misawa S, Abe T: Bilineage response in refractory aplastic anemia patients following long term administration of recombinant human granulocyte colony stimulating factor 1. Eur J Haematol 48:41, 1992
13. Champlin R, Nimer SR, Ireland P, Oette DH, Golde DW: Treatment of refractory aplastic anemia with recombinant human granulocyte macrophage colony stimulating factor. Blood 73:694, 1989
14. Ganser A, Lindemann A, Ottmann OG, Seipelt G, Hess U, Geissler G, Kanz L, Frish J, Schulz G, Hermann F, Mertelsmann R, Hoelzer D: Sequential in vivo treatment with two recombinant human hemopoietic growth factors (interleukin 3 and granulocyte macrophage colony stimulating factor) as a new therapeutic modality to stimulate hematopoiesis: Result of a phase I study. Blood 79:2583, 1992
15. Koijma S, Matsuyama T: Stimulation of granulopoiesis by high dose recombinant human granulocyte colony stimulating factor in children wilh aplastic anemia and very severe neutropenia. Blood 83:1474, 1994
16. Kaplan EL, Meier P: Non-parametric estimation for incomplete observations. J Am Stat Assoc 53:457, 1958
17. Marmont AM, Bacigalupo A, Van Lint MT, Podestà M, Frassoni F, Risso M, Cerri R, Rossi E, Damasio E, Santini G, Carella AM, Giordano D, Kreeftenberg JG: Treatment of severe aplastic anemia with sequential immunosuppression. Exp Hematol 11:856, 1983
18. Schrezenmeier H, Marin P, Ragavachar A, McCann S, Hows J, Gluckman E, Nissen C, van't Veer-Korthof ET, Ljungman P, Hinterberger W, van Lint MT, Frickhofen N, Bacigalupo A, for the EBMT SAA Working Party: Relapse of aplastic anaemia after immunosuppressive treatment: A report from the European Bone Marrow Transplantation Group SAA Working Party. Br J Haematol 85:371, 1993
19. Bacigalupo A, Piaggio G, Podestà M, van Lint MT, Valbonesi M, Lercari G, Mori PG, Pasino M, Franchini E, Rivabella L, Figari O, Sogno G, Raffo MR, Marmont AM: Collection of peripheral blood hemopoietic progenitors (PBHP) from patients with severe aplastic anemia (SAA) after prolonged administration of granulocyte colony-stimulating factor. Blood 82:1410, 1993
20. Bacigalupo A, Tong J, Piaggio G, Podestà M, Hoffman R: Early hemopoietic progenitors collected from the peripheral blood of patients with severe aplastic anemia after prolonged in vivo G-CSF treatment. Blood 82:1410, 1993
21. Torok Storb B, Doney K, Sale G, Thomas ED: In vitro tests for distinguishing possible immune mediated aplastic anemia from transfusion induced sensitization. Blood 55:2111, 1980
22. Faille A, Barrett AJ, Balitrand N, Ketels F, Gluckman E, Nayean Y: Effect of antilymphocyte globulin on granulocyte precursor in aplastic anaemia. Br J Haematol 42:371, 1979
23. Hunter RF, Mold NG, Mitchell RB, Huang AT: Differentiation of normal marrow and HL60 cells induced by antithymocyte globulin. Med Sci 82:4823, 1985
24. Huang AT, Mold NG, Zhang SF: Antithymocyte globulin stimulates human hematopoietic progenitor cells. Med Sci 84:5942, 1987
25. Kawano Y, Nissen C, Gratwohl A, Speck B: Immunostimulatory effects of different antilymphocyte globulin preparations: A possible clue to their clinical effect. Br J Haematol 68:115, 1988
26. Barbano GC, Schenone A, Roncella S, Ohio R, Corcione A, Mori PG, Ferrarini M, Pistoia V: Anti-lymphocyte globulin stimulates normal human T cells to proliferate and to release lymphokines in vitro. A study at the clonal level. Blood 72:956, 1988
27. Tong J, Bacigalupo A, Piaggio G, Figari O, Sogno G, Marmont AM: In vitro response of T cells from severe aplastic anemia (SAA) patients to antilymphocyte globulin (ALG) and phytohemagglutinin (PHA): Colony stimulating activity and lymphokine production. Exp Hematol 19:312, 1991
28. Doney K, Kopecky K, Storb R, Buckner CD, Singer J, Anasetti C, Appelbaum F, Beatty P, Bensinger W, Berenson R, Clift R, Deeg HJ, Hansen J, Roger H, Loughran T, Martin P, Petersen FB, Sale G, Sanders J, Sullivan K, Stewart P, Weiden P, Witherspoon R, Thomas ED: Long-term comparison of immunosuppressive therapy with antithymocyte globulin to bone marrow transplantation in aplastic anemia, in Shahidi NT (ed): Aplastic Anemia and Other Bone Marrow Failure Syndromes. 1990, p 104
29. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann A, Ragavashar A, Frickhofen N, Wursh A, Marmont AM Gordon Smith EC: Bone marrow transplantation (BMT) versus immunosuppression (IS) for the treatment of severe aplastic anemia (SAA): A report of the EBMT SAA Working Party. Br J Haematol 70:177, 1988
30. Sociè G, Amar MH, Bacigalupo A, Hows J, Tichelli A, Ljungman P, McCann S, Frickhofen N, van't Veer Korthof E, Gluckman E: Malignancies occurring after treatment of aplastic anemia: A survey conducted by the Severe Aplastic Anaemia Working Party of the European Group for Bone Marrow Transplantation. N Engl J Med 329:1152, 1993